Truist Securities Maintains Hold on Zimmer Biomet Holdings, Lowers Price Target to $148
Portfolio Pulse from richadhand@benzinga.com
Truist Securities analyst Richard Newitter maintains a 'Hold' rating on Zimmer Biomet Holdings (NYSE:ZBH) and lowers the price target from $153 to $148.
August 04, 2023 | 11:46 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Truist Securities has maintained a 'Hold' rating on Zimmer Biomet Holdings and lowered the price target from $153 to $148.
The news directly pertains to Zimmer Biomet Holdings (ZBH). The 'Hold' rating suggests that the analyst sees the stock as fairly valued at current levels. However, the lowering of the price target could potentially have a negative impact on investor sentiment, which might put some downward pressure on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100